Project Number 1R43AG043278-01 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for Intranasal Delivery of Peptide Drugs to the Brain Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator DEWJI, NAZNEEN N Principal Investigator First Name NAZNEEN Principal Investigator Last Name DEWJI Awardee Organization CENNA BIOSCIENCES, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-11-096: PHS 2011-02 OMNIBUS SOLICITATION OF THE NIH, CDC, FDA AND ACF FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44]) FY Overall Cost $261,779 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Related Resources Repository [AlzPED] Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease
